FDA approves first drug to delay onset of Type 1 diabetes
(SILVER SPRING, Md.) -- For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes.Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio... Read More.
